(Q54604723)

1 June 2018

title

Brain-derived neurotrophic factor is a potential osteoclast stimulating factor in multiple myeloma. (English)

1 reference

1 June 2018

author name string

Chun-Yan Sun

1

1 reference

1 June 2018

Zhang-Bo Chu

2

1 reference

1 June 2018

Xiao-Mei She

3

1 reference

1 June 2018

Lu Zhang

4

1 reference

1 June 2018

Lei Chen

5

1 reference

1 June 2018

Li-Sha Ai

6

1 reference

1 June 2018

Yu Hu

7

1 reference

1 June 2018

language of work or name

English

0 references

publication date

28 May 2011

1 reference

1 June 2018

International Journal of Cancer

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

1 June 2018

volume

130

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

827-836

1 reference

1 June 2018

Pathogenesis of myeloma bone disease

cites work

1 reference

Bone destruction in multiple myeloma.

21 January 2018

1 reference

Pathogenesis and management of bone lesions in multiple myeloma

21 January 2018

1 reference

Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myeloma

21 January 2018

1 reference

Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology

21 January 2018

1 reference

Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients.

21 January 2018

1 reference

Myeloma bone disease: recent advances in biology, diagnosis, and treatment

21 January 2018

1 reference

Pathogenesis of myeloma bone disease

21 January 2018

1 reference

Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma.

21 January 2018

1 reference

The pathogenesis of the bone disease of multiple myeloma.

21 January 2018

1 reference

Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion

21 January 2018

1 reference

Brain-derived neurotrophic factor promotes growth and migration of multiple myeloma cells

21 January 2018

1 reference

A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival.

21 January 2018

1 reference

Expression of neurotrophins and their receptors in human bone marrow

21 January 2018

1 reference

High-affinity neurotrophin receptors and ligands promote leukemogenesis

21 January 2018

1 reference

Perineural invasion in adenoid cystic carcinoma: Its causation/promotion by brain-derived neurotrophic factor

21 January 2018

1 reference

Autocrine expression of neurotrophins and their receptors in prostate cancer

21 January 2018

1 reference

BDNF dependence in neuroblastoma

21 January 2018

1 reference

Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome

21 January 2018

1 reference

Neurotrophin signalling pathways regulating neuronal apoptosis

21 January 2018

1 reference

Differential gene expression pattern of neurotrophins and their receptors during neuronal differentiation of rat bone marrow stromal cells.

21 January 2018

1 reference

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease

21 January 2018

1 reference

Identification of brain-derived neurotrophic factor as a novel angiogenic protein in multiple myeloma

21 January 2018

1 reference

Brain-derived neurotrophic factor induces proliferation, migration, and VEGF secretion in human multiple myeloma cells via activation of MEK-ERK and PI3K/AKT signaling

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26059

1 reference

1 June 2018

1 reference

1 June 2018